Navigation Links
Asthmatics May Be At Risk for Lung Disease In The Future

COPD refers to a group of diseases that affect the lungs, including emphysema and chronic bronchitis. COPD is characterized by permanent // lung damage and irreversible airflow limitation. With asthma, on the other hand, the airways become inflamed, causing airflow obstruction and difficulty breathing, but the damage to the lungs is not thought to be permanent. Plus, the symptoms of asthma can usually be relieved spontaneously or with medication.

Asthmatics may have reason to worry about future lung diseases. According to a 20-year study, it was found that adults with asthma may have an increased risk of developing chronic obstructive pulmonary disease. During the research it was observed that active asthmatics are 12-times more likely to develop COPD later in life than non-asthmatics. However, researchers did find a significant difference between active and inactive asthmatics -- those who were previously diagnosed with asthma but did not experience symptoms. Thus researchers say this suggests that an increased risk is only associated with those who currently have asthma.

According to researchers smoking has been described as the main risk factor for the development of COPD. However, less than 20 percent of cigarette smokers acquire COPD, suggesting that other factors convey significant additional risk.Thus minimizing asthmatics’ exposure to risk factors such as tobacco smoke and air pollution may delay disease progression to COPD. Some specialists also suggest that effective anti-inflammatory therapy at the onset of asthma may decrease the likelihood of developing COPD.
'"/>




Page: 1

Related medicine news :

1. What happens when Asthmatics consume Aspirin?
2. Asthmatics at increased risk of lung cancer
3. Easing Fears Among Asthmatics
4. Biofeedback Found To Reduce Steroid Dependence In Asthmatics
5. Reducing Corticosteriod Use In Asthmatics
6. Vitamin C – Supplementation A Boon For Asthmatics
7. Asthmatics need to be on guard for Major Diseases
8. Asthmatics, it pays to quit smoking
9. New Zealand To Give More Choice Of Drugs To Asthmatics
10. Monoclonal Antibody Reduces Exacerbations in Asthmatics
11. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... Plano, TX (PRWEB) , ... July 27, 2017 ... ... technology and outsourced services, announces the internal promotion of Elrene Clinkscales to Vice ... Operations – Claims & Remittance Management, reporting to Derek Morkel, chief executive officer ...
(Date:7/27/2017)... ... 2017 , ... Team Novo Nordisk, the world’s first all-diabetes professional cycling team, ... a stagiaire for the remainder of the 2017 season. One of our best development ... Tour of Utah. , “Every season we are excited to move an athlete from ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: Ashley D. Beall, ... in drug therapy for patients living with relapsing and primary multiple sclerosis that ... cell targeted therapy that has been proven to significantly reduce signs of disease ...
(Date:7/26/2017)... ... July 26, 2017 , ... “We are dentists and we thought there ... Jose, Calif., “so we invented the MAGNETIC/ LOCK BRACKETS.” , The patent-pending MAGNETIC/ LOCK ... In doing so, it offers an effective alternative to traditional braces. As a result, ...
(Date:7/26/2017)... ... July 26, 2017 , ... “We are thrilled to be ... for patients to schedule an appointment online in real time,” said Keith English, LocalMed ... Smiles provider directory will bring more Six Month Smiles patients to their providers.” , ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... , July 13, 2017  New York City-based market research ... markets should be aware of.  From new products to new ... detailed in a recently completed study, Potential Pipeline Disruptors ... 1.  Age-Driven Growth - True ... been aware of the impact the growing population and, to ...
(Date:7/11/2017)...  Bayer has awarded grants totaling more than $2 million ... prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and ... and Uniformed Services University of the Health Sciences in ... recipients were announced last night during a reception at the ... Berlin, Germany . ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
Breaking Medicine Technology: